Triokris (Trientine Hydrochloride 250mg Capsules) 100

Generic Name:Brand Name:Strength:Dosage Form:Route of Use:Therapeutic Class:Indication:Packaging:Shelf Life:Standards:Storage:Company:

Triokris™ is a generic version of Trientine Hydrochloride 250 mg, developed and manufactured in a USFDA-approved facility by Ikris Pharma Network Pvt. Ltd., India. This medicine is available in India for the management of Wilson’s Disease, a rare genetic disorder that causes toxic copper accumulation in the most important organs, like the liver, brain, and eyes.
Triokris binds excess copper and enhances its urinary excretion, helping restore copper balance and prevent long-term organ damage. It is widely recognised as a safe and effective alternative to D-Penicillamine, suitable for long-term therapy. 

Dosage & Administration - 

       Triokris Capsule:

• Adults (≥13 years): The initial dose is 750 to 1250 mg per day, divided into two, three, or four doses daily.
• Children (≤12 years): The initial dose is 500 to 750 mg per day, given in divided doses two to four times daily.
• Maximum dose: Up to 2000 mg/day for adults and 1500 mg/day for pediatric patients aged 12 years or under.

    Administration Guidelines:

• Take Trientine Hydrochloride Capsules on an empty stomach, at least one hour before meals or two hours after meals.
• Maintain at least a one-hour gap between Triokris and any other medication, food, or milk.
• Capsules should be swallowed whole with water — do not open or chew the capsules.
• Maintain consistent dosing times each day to ensure steady copper control and effective treatment results.